Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 4/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | MMP9 | P14780 | 1/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30412501 | 0.87 | NPSR1 (0.39) | NPSR1LMNAMEN1KMT2ATDP1 | |
| SCHEMBL22747292 | 0.86 | ALDH1A1 (0.48) | NPSR1LMNAMEN1KMT2ATDP1 | |
| SCHEMBL7721260 | 0.83 | — | — | |
| SCHEMBL6683739 | 0.83 | NPSR1 (0.36) | NPSR1LMNAMEN1KMT2ATDP1 | |
| SCHEMBL23692773 | 0.81 | — | — | |
| SCHEMBL456533 | 0.81 | — | — | |
| SCHEMBL11504379 | 0.81 | CA12 (0.54) | NPSR1LMNAMEN1KMT2AALDH1A1 | |
| SCHEMBL12703379 | 0.78 | ALDH1A1 (0.40) | NPSR1LMNAMEN1KMT2ATDP1 | |
| SCHEMBL3069346 | 0.77 | CA12 (0.35) | NPSR1LMNAMEN1KMT2ATDP1 | |
| SCHEMBL23662762 | 0.77 | POLB (0.41) | NPSR1LMNAMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 655 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250197449-A1 | Synthetic Process for Production of Modified GCC Receptor Agonists | IRONWOOD PHARMACEUTICALS, INC. | 2025-06-19 | — | — | US | claimed |
| EP-3816325-B1 | ACIDIC AQUEOUS SILVER-NICKEL ALLOY ELECTROPLATING COMPOSITIONS AND METHODS | DUPONT ELECTRONIC MAT INTERNATIONAL LLC (US) | 2025-05-07 | — | — | EP | claimed |
| CN-111384406-B | Antioxidant for fuel cell, membrane electrode assembly including the same and method of preparing the antioxidant | 现代自动车株式会社 | 2025-01-14 | — | — | CN | claimed |
| CN-115124552-B | Preparation method of deacetylated cefathiamidine | 国药集团威奇达药业有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-113906321-B | Polarizing plate, method for manufacturing same, and image display device | 住友化学株式会社 | 2024-10-15 | — | — | CN | claimed |
| EP-4436981-A1 | SYNTHETIC PROCESS FOR PRODUCTION OF MODIFIED GCC RECEPTOR AGONISTS | Ironwood Pharmaceuticals, Inc. (US) | 2024-10-02 | — | — | EP | claimed |
| US-12080927-B2 | Antioxidant for fuel cells, membrane electrode assembly including the same and method for preparing antioxidant | HYUNDAI MOTOR COMPANY (KR) | 2024-09-03 | — | — | US | claimed |
| CN-117843531-A | Preparation method of N, N' -diisopropylcarbodiimide | 江苏睿实生物科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115449136-B | Accelerator composition of rubber nanocomposite as well as preparation method and application thereof | 浙江大学 | 2024-02-27 | — | — | CN | claimed |
| CN-114939482-B | Method for improving molybdenite flotation index through reduction fine grinding | 西安建筑科技大学 | 2024-02-20 | — | — | CN | claimed |
| EP-1501874-A4 | ABRASION RESISTANT ELASTOMERIC COMPOSITIONS | EXXONMOBIL CHEM PATENTS INC (US) | 2005-08-31 | — | — | EP | claimed |
| CN-1642988-A | Abrasion resistant elastomeric compositions | EXXONMOBIL CHEM PATENTS INC (US) | 2005-07-20 | — | — | CN | claimed |
| JP-2005520022-A | — | — | 2005-07-07 | — | — | JP | claimed |
| US-20050085594-A1 | Abrasion resistant elastomeric compositions | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-04-21 | — | — | US | claimed |
| EP-1001054-B1 | Tin-copper alloy electroplating bath and plating process therewith | UYEMURA C & CO LTD (JP) | 2005-04-20 | — | — | EP | claimed |
| EP-1501874-A1 | ABRASION RESISTANT ELASTOMERIC COMPOSITIONS | Exxonmobil Chemical Patents Inc. (US) | 2005-02-02 | — | — | EP | claimed |
| WO-2003078475-A1 | ABRASION RESISTANT ELASTOMERIC COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS, INC. (US) | 2003-09-25 | — | — | WO | claimed |
| US-6508927-B2 | Bath contains an inorganic or organic acid or a water-soluble salt thereof, and one or more thioamide compounds or thiol compounds; forms a tin-copper alloy deposit, in place of tin-lead alloy plating, on electronic parts | C. UYEMURA & CO., LTD. (JP) | 2003-01-21 | — | — | US | claimed |
| US-20020104763-A1 | TIN - COPPER ALLOY ELECTROPLATING BATH AND PLATING PROCESS THEREWITH | C. UYEMURA & CO., LTD. (JP) | 2002-08-08 | — | — | US | claimed |
| EP-1001054-A2 | Tin-copper alloy electroplating bath and plating process therewith | C. UYEMURA & CO, LTD (JP) | 2000-05-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197449-A1 | Synthetic Process for Production of Modified GCC Receptor Agonists | GNRHR, SCTR, GIPR | NPSR1 196/4885LMNA 4613/4885MEN1 1072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.